TITLE

Advances in the understanding of Fanconi anemia tumor suppressor pathway

AUTHOR(S)
Pickering, Anna; Zhang, Jun; Panneerselvam, Jayabal; Peiwen Fei
PUB. DATE
December 2013
SOURCE
Cancer Biology & Therapy;Dec2013, Vol. 14 Issue 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
93402865

 

Related Articles

  • Fanconi Anemia Research Opens New Doors in Understanding of Cancer. Erdman, Jeanne // JNCI: Journal of the National Cancer Institute;8/20/2003, Vol. 95 Issue 16, p1190 

    Examines the effectiveness of Fanconi anemia gene research in the study of cancers. Recognition of the study of hereditary diseases in understanding tumor suppression genes; Resemblance between breast tumor mutated cells and cells of Fanconi patients; Sensitivity of the cells to chromosome...

  • A new gene on the X involved in Fanconi anemia. Rahman, Nazneen; Ashworth, Alan // Nature Genetics;Nov2004, Vol. 36 Issue 11, p1142 

    A new study shows that Fanconi anemia complementation group B is caused by mutations in a previously uncharacterized gene located on the X chromosome. Its unique chromosomal localization identifies FANCB as a potential weak link in a key DNA-repair and tumor-suppressor pathway.

  • Familial Central Nervous System Tumor Syndromes. Hottinger, Andreas F.; Khakoo, Yasmin; Abrey, Lauren E. // Current Cancer Therapy Reviews;2006, Vol. 2 Issue 4, p281 

    The vast majority of nervous system neoplasms occur sporadically. However, most adult and pediatric tumors have a hereditary equivalent. These hereditary forms are an invaluable resource in the identification of genes that may be important for sporadic tumor development. In recent years there...

  • The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Mosedale, Georgina; Niedzwiedz, Wojciech; Alpi, Arno; Perrina, Franco; Pereira-Leal, Jose B; Johnson, Mark; Langevin, Frederic; Pace, Paul; Patel, Ketan J // Nature Structural & Molecular Biology;Sep2005, Vol. 12 Issue 9, p763 

    The helicase-associated endonuclease for fork-structured DNA (Hef) is an archaeabacterial protein that processes blocked replication forks. Here we have isolated the vertebrate Hef ortholog and investigated its molecular function. Disruption of this gene in chicken DT40 cells results in genomic...

  • Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Taniguchi, Toshiyasu; Tischkowitz, Marc; Ameziane, Najim; Hodgson, Shirley V.; Mathew, Christopher G.; Joenje, Hans; Mok, Samuel C.; D'Andrea, Alan D. // Nature Medicine;May2003, Vol. 9 Issue 5, p568 

    Ovarian tumor cells are often genomically unstable and hypersensitive to cisplatin. To understand the molecular basis for this phenotype, we examined the integrity of the Fanconi anemia-BRCA (FANC-BRCA) pathway in those cells. This pathway regulates cisplatin sensitivity and is governed by the...

  • FANCL, as in ligase. Grompe, Markus // Nature Genetics;Oct2003, Vol. 35 Issue 2, p113 

    Biochemical purification has identified a new component of the Fanconi anemia complex. The protein has ubiquitin ligase activity and may be the long-sought enzyme responsible for monoubiquitination of Fanconi anemia protein FANCD2. Genetic pathways that control genomic stability have long been...

  • Fanconi-like crosslink repair in yeast. Daee, Danielle L.; Myung, Kyungjae // Genome Integrity;2012, Vol. 3 Issue 1, p7 

    Interstrand crosslinks covalently link complementary DNA strands, block replication and transcription, and can trigger cell death. In eukaryotic systems several pathways, including the Fanconi Anemia pathway, are involved in repairing interstrand crosslinks, but their precise mechanisms remain...

  • Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy. Ukhyun Jo; Hyungjin Kim // Molecules & Cells (Korean Society for Molecular & Cellular Biolo;Sep2015, Vol. 38 Issue 8, p669 

    Genome instability, primarily caused by faulty DNA repair mechanisms, drives tumorigenesis. Therapeutic interventions that exploit deregulated DNA repair in cancer have made considerable progress by targeting tumor-specific alterations of DNA repair factors, which either induces synthetic...

  • The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Levran, Orna; Attwooll, Claire; Henry, Rashida T.; Milton, Kelly L.; Neveling, Kornelia; Rio, Paula; Batish, Sat Dev; Kalb, Reinhard; Velleuer, Eunike; Barral, Sandra; Ott, Jurg; Petrini, John; Schindler, Detlev; Hanenberg, Helmut; Auerbach, Arleen D. // Nature Genetics;Sep2005, Vol. 37 Issue 9, p931 

    Seven Fanconi anemia–associated proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) form a nuclear Fanconi anemia core complex that activates the monoubiquitination of FANCD2, targeting FANCD2 to BRCA1-containing nuclear foci. Cells from individuals with Fanconi anemia of...

  • Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Lensch, M W; Rathbun, R K; Olson, S B; Jones, G R; Bagby, G C // Leukemia (08876924);Nov99, Vol. 13 Issue 11, p1784 

    Specific chromosomal deletions are commonly found in bone marrow cells of children with Fanconi anemia (FA) whose disease has evolved to myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Identical deletions are found in adults with MDS/AML with a history of exposure to alkylating...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics